← Back to patent-cliff list
CAS 496-16-2
2,3-dihydrobenzofuran
Codes: Anaprazole Sodium-001
Application context (from source-drug indications)
Duodenal ulcerAnaprazole SodiumHelicobacter pylori infectionAnaprazole SodiumPeptic oesophagitisAnaprazole SodiumOesophageal diseaseAnaprazole Sodium食管功能障碍Anaprazole SodiumOesophagitisAnaprazole Sodium
Source drugs (routes using this intermediate)
| Drug | Tier | Expiry |
|---|---|---|
| Anaprazole Sodium | Tier C — Watch / trade | - |
Position in synthesis routes (up/downstream chain)
Ordered by route registration; left → right is the synthesis direction. The highlighted node is the current CAS; others link to their own profiles.
2,3-dihydrobenzofuran→5-nitro-2,3-dihydrobenzofuran→2,3-dihydrobenzofuran-5-amine→N-(2,3-dihydrobenzofuran-5-yl)acetamide→N-(6-nitro-2,3-dihydrobenzofuran-5-yl)acetamide→6-nitro-2,3-dihydrobenzofuran-5-amine→2,3-dihydrobenzofuran-5,6-diamine→potassium O-ethyl carbonodithioate→6,7-dihydro-3H-benzofuro[5,6-d]imidazole-2-thiol→2-(chloromethyl)-4-(3-methoxypropoxy)-3-methylpyridine→2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)thio)-6,7-dihydro-3H-benzofuro[5,6-d]imidazole→(R)-2-(((4-(3-methoxypropoxy)-3-methylpyridin-2-yl)methyl)sulfinyl)-6,7-dihydro-3H-benzofuro[5,6-d]imidazole
Intermediates available on this site
Side-by-side comparison of all listed offers on this CAS; price bands are list-price ranges, final price subject to RFQ confirmation.
| Supplier | Product | Price band | MOQ | Lead time | Qualifications | Action |
|---|---|---|---|---|---|---|
| Unibest Nantong cGMP Site | 2,3-Dihydrobenzofuran Pharmaceutical Intermediates | On request | On request | On request | — |
This is a CAS-level registry record: registrations across routes are merged. Supplier offers and buyer demands will be matched on this CAS as the primary key.